Hims Inc
US$ 21.80
tirzepatide heart In the SUMMIT trial, researchers examined cardiovascular outcomes of treatment with in patients with failure with preserved ejection fraction and obesity. Full trial results and Plain Language Summary: https://nej.md/4hRGaTY Medthreads ESC 2025: study supports use
Description
Because both compounds are either newly approved in a single market (mazdutide) or still investigational everywhere else (retatrutide), any dosing decision belongs with a qualified clinical trial investigator or licensed prescriber, not a self-directed protocol
These medications mimic the action of GLP-1, a hormone integral to regulating appetite and food intake
Can you take Jardiance with Rybelsus
This trial led the FDA to expand Wegovy's label to include reducing cardiovascular risk in people with obesity
